+

TWI799365B - 用於先天性痙攣症之瘟疫病毒疫苗 - Google Patents

用於先天性痙攣症之瘟疫病毒疫苗 Download PDF

Info

Publication number
TWI799365B
TWI799365B TW105128166A TW105128166A TWI799365B TW I799365 B TWI799365 B TW I799365B TW 105128166 A TW105128166 A TW 105128166A TW 105128166 A TW105128166 A TW 105128166A TW I799365 B TWI799365 B TW I799365B
Authority
TW
Taiwan
Prior art keywords
congenital tremors
pestivirus vaccines
pestivirus
vaccines
tremors
Prior art date
Application number
TW105128166A
Other languages
English (en)
Other versions
TW201718007A (zh
Inventor
喬瑟夫 吉爾伯特 維多利亞
亞比 雷 派特森
卡力 安 維賽克
亞倫 V 艾爾
莉 安 霍伯斯
貝力 蘿倫 阿魯達
保羅 亨瑞克 伊利亞斯 阿魯達
得魯 羅伯特 麥格史戴特
肯特 傑 薛瓦茲
Original Assignee
德商百靈佳殷格翰維美迪加股份有限公司
美國愛奧華州立大學研究基金會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56889250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI799365(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 德商百靈佳殷格翰維美迪加股份有限公司, 美國愛奧華州立大學研究基金會 filed Critical 德商百靈佳殷格翰維美迪加股份有限公司
Publication of TW201718007A publication Critical patent/TW201718007A/zh
Application granted granted Critical
Publication of TWI799365B publication Critical patent/TWI799365B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW105128166A 2015-08-31 2016-08-31 用於先天性痙攣症之瘟疫病毒疫苗 TWI799365B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562212124P 2015-08-31 2015-08-31
US62/212,124 2015-08-31

Publications (2)

Publication Number Publication Date
TW201718007A TW201718007A (zh) 2017-06-01
TWI799365B true TWI799365B (zh) 2023-04-21

Family

ID=56889250

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105128166A TWI799365B (zh) 2015-08-31 2016-08-31 用於先天性痙攣症之瘟疫病毒疫苗

Country Status (21)

Country Link
US (2) US9920302B2 (zh)
EP (1) EP3344289B1 (zh)
JP (1) JP7046607B2 (zh)
KR (1) KR20180042167A (zh)
CN (1) CN108135993B (zh)
AU (1) AU2016315796B2 (zh)
BR (1) BR112017028224A2 (zh)
CA (1) CA2996629A1 (zh)
CL (1) CL2018000513A1 (zh)
DK (1) DK3344289T3 (zh)
EA (1) EA036116B1 (zh)
ES (1) ES2778649T3 (zh)
HK (1) HK1256205A1 (zh)
MX (1) MX381745B (zh)
MY (1) MY189501A (zh)
PH (1) PH12017501795B1 (zh)
PL (1) PL3344289T3 (zh)
PT (1) PT3344289T (zh)
TW (1) TWI799365B (zh)
UA (1) UA124140C2 (zh)
WO (1) WO2017040672A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
PT3344289T (pt) 2015-08-31 2020-04-02 Boehringer Ingelheim Vetmedica Gmbh Vacinas de pestivírus para tremores congénitos
CN106801109B (zh) * 2017-03-24 2021-03-05 温氏食品集团股份有限公司 一种猪非典型瘟病毒rt-pcr检测特异性引物、试剂盒及检测方法
KR102293892B1 (ko) 2018-09-19 2021-08-24 주식회사 엘지화학 황-탄소 복합체의 제조방법, 그에 의해 제조된 황-탄소 복합체, 상기 황-탄소 복합체를 포함하는 양극, 및 상기 양극을 포함하는 리튬 이차 전지
CN109295014B (zh) * 2018-10-30 2021-08-17 华中农业大学 一种非典型猪瘟病毒e2蛋白重组杆状病毒及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096377A2 (en) 2000-06-15 2001-12-20 Purdue Research Foundation Vaccine for congenital tremors in pigs
CN104178505A (zh) * 2014-09-01 2014-12-03 华中农业大学 一种表达猪瘟病毒e2基因重组病毒及制备方法与应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US382425A (en) 1888-05-08 Brandt
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3456053A (en) * 1966-05-06 1969-07-15 Pfizer & Co C Inactivated hog cholera virus vaccine
US4394448A (en) 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4769331A (en) 1981-09-16 1988-09-06 University Patents, Inc. Recombinant methods and materials
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5364773A (en) 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
IL84154A0 (en) 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
WO1990001543A1 (fr) 1988-07-29 1990-02-22 Intracel Corporation Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
CA2003300A1 (en) 1988-11-21 1990-05-21 Franklin Volvovitz Skin test and test kit for aids
ATE277193T1 (de) 1989-03-21 2004-10-15 Vical Inc Expression von exogenen polynukleotidsequenzen in wirbeltieren
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5591439A (en) 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
GB9001766D0 (en) 1990-01-25 1990-03-28 Univ Court Of The University O Vaccines
EP0575491B1 (en) 1991-03-07 2003-08-13 Virogenetics Corporation Genetically engineered vaccine strain
US5997878A (en) 1991-03-07 1999-12-07 Connaught Laboratories Recombinant poxvirus-cytomegalovirus, compositions and uses
ATE118352T1 (de) 1991-06-06 1995-03-15 Stichting Centr Diergeneeskund Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
DE69214657T2 (de) 1991-08-26 1997-04-17 David Allen Benfield Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas)
AU2696792A (en) 1991-09-16 1993-04-27 David A Benfield Vaccine for mystery swine disease and method for diagnosis thereof
WO1993007898A1 (en) 1991-10-14 1993-04-29 Akzo Nobel N.V. Porcine reproductive respiratory syndrome vaccine and diagnostic
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5801029A (en) 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
EP0620277A1 (en) 1993-03-18 1994-10-19 Merck & Co. Inc. Nucleic acid pharmaceuticals
FR2711670B1 (fr) 1993-10-22 1996-01-12 Pasteur Institut Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
DE69536091D1 (de) 1994-01-27 2010-09-09 Univ Massachusetts Medical Immunisierung durch Impfung von DNS Transkriptionseinheit
DK0676467T3 (da) 1994-04-11 2002-01-21 Akzo Nobel Nv Europæiske vaccinestammer af det porcine reproduktive respiratoriske syndromvirus (PRRSV)
DE69534289T2 (de) 1994-04-29 2006-04-27 Baxter Healthcare S.A. Rekombinante Pockenviren mit fremden Polynukleotiden in wichtigen Regionen
DE69632658T2 (de) 1995-03-14 2005-06-09 Akzo Nobel N.V. Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
CA2215162A1 (en) 1995-03-23 1996-09-26 Cantab Pharmaceuticals Research Limited Vectors for gene delivery
WO1998000166A1 (en) 1996-07-03 1998-01-08 Merial, Inc. Recombinant canine adenovirus (cav) containing exogenous dna
DE69704011T2 (de) 1996-10-09 2001-06-07 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV)
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
US6183752B1 (en) 1997-02-05 2001-02-06 Pasteur Merieux Serums Et Vaccins Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
ES2261329T3 (es) * 2000-04-21 2006-11-16 Akzo Nobel N.V. Mutantes de pestivirus y vacunas que los contienen.
US6841364B2 (en) 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
CN107002047B (zh) * 2014-12-19 2022-02-08 英特维特国际股份有限公司 瘟病毒
WO2016176624A2 (en) 2015-04-30 2016-11-03 Kansas State University Research Foundation Porcine pestvirus, vaccines, and assays
PT3344289T (pt) * 2015-08-31 2020-04-02 Boehringer Ingelheim Vetmedica Gmbh Vacinas de pestivírus para tremores congénitos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096377A2 (en) 2000-06-15 2001-12-20 Purdue Research Foundation Vaccine for congenital tremors in pigs
CN104178505A (zh) * 2014-09-01 2014-12-03 华中农业大学 一种表达猪瘟病毒e2基因重组病毒及制备方法与应用

Also Published As

Publication number Publication date
EP3344289B1 (en) 2020-01-29
CN108135993B (zh) 2022-03-22
US10633637B2 (en) 2020-04-28
WO2017040672A1 (en) 2017-03-09
MY189501A (en) 2022-02-16
JP7046607B2 (ja) 2022-04-04
JP2018525324A (ja) 2018-09-06
MX381745B (es) 2025-03-13
TW201718007A (zh) 2017-06-01
EA201792593A1 (ru) 2018-08-31
AU2016315796A1 (en) 2017-10-19
PH12017501795B1 (en) 2023-10-11
PL3344289T3 (pl) 2021-01-11
HK1256205A1 (zh) 2019-09-13
CN108135993A (zh) 2018-06-08
EP3344289A1 (en) 2018-07-11
CL2018000513A1 (es) 2019-01-11
US20180171307A1 (en) 2018-06-21
KR20180042167A (ko) 2018-04-25
ES2778649T3 (es) 2020-08-11
US20170058266A1 (en) 2017-03-02
CA2996629A1 (en) 2017-03-09
PT3344289T (pt) 2020-04-02
AU2016315796B2 (en) 2022-08-04
UA124140C2 (uk) 2021-07-28
EA036116B1 (ru) 2020-09-30
PH12017501795A1 (en) 2018-04-02
US9920302B2 (en) 2018-03-20
BR112017028224A2 (pt) 2018-09-11
DK3344289T3 (da) 2020-04-14
MX2017016252A (es) 2018-04-20

Similar Documents

Publication Publication Date Title
EP3368736A4 (en) CONTROL DEVICES FOR OPTICALLY SWITCHED DEVICES
EP3325443A4 (en) PROCESS FOR THE PREPARATION OF PRIDOPIDINE
EP3333096A4 (en) OPENING STOP
EP3298623A4 (en) Gas cabinets
EP3360047A4 (en) SECURE SUBSYSTEM
EP3303866A4 (en) Improved isolation device
EP3257149A4 (en) Oscillating-resonant-module controller
EP3142287B8 (en) Synchronising devices
HK1256205A1 (zh) 用於先天性震顫的瘟病毒疫苗
EP3267848A4 (en) Support means
EP3307621A4 (en) RAMP
EP3265100A4 (en) PROCESSES FOR PREPARING FLUOROKETOLIDES
EP3381911A4 (en) PROCESS FOR THE PREPARATION OF VALEROLACTONE
EP3345996A4 (en) METHOD FOR PRODUCING GAMMA-GLUTAMYL-VALYL-GLYCIN
EP3240376A4 (en) Cabinet
AU2016363347B2 (en) Marking-out aid
EP3348544A4 (en) PROCESS FOR THE PRODUCTION OF CAPROLACTAM
EP3398959A4 (en) METHOD OF PREPARING LIXISENNATIDE
EP3226995A4 (en) Solid adjuvant defoamer
AU2015905184A0 (en) Dinkum Swinger
EP3253732A4 (en) 4-azidobutylamines and processes for preparing
AU2015904456A0 (en) Process
AU2015905390A0 (en) Cabinet
AU2015903297A0 (en) IDAZ09 Technology
AU2015903298A0 (en) IDAZ09 Technology

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载